Our Doctors

Matthew Butler, M.D.

Hematology/Oncology

Internal Medicine

Make an Appointment

NOTE : If you're an existing patient, please connect via MyChart

About Me
About Matthew Butler, M.D.

Dr. Matthew Butler is a faculty member of the division of hematology and oncology. Dr. Butler grew up in Nova Scotia, Canada, and worked in Toronto as a software developer before starting medical school. He completed his specialty training at UT Health San Antonio with a focus on blood cancers. His practice covers the full range of blood disorders, with a special interest in multiple myeloma. His clinical research focus is aimed at finding better treatments for malignant lymphomas

Gender
- Male
Credentials
Credentials

Certifications
- American Board of Internal Medicine
Education
Medical School: Saba University School of Medicine

Residency: Geisinger Medical Center

Fellowship: University of Texas Health Science Center at San Antonio
Locations & Contact

Locations & Contact

Urschel Building

7979 Wurzbach Road
San Antonio, TX 78229

Make an appointment

29.5130016, -98.5806009

Dr. Butler is very informative. He's easy to speak to. He's very caring and I really liked his bed side manner.

Patient
Research & Publications

Research & Publications

No Research & Publications
Clinical Trials

Clinical Trials

Type of Cancer

Leukemia, other

ClinicalTrials.gov Identifier

NCT03580655

Principal Investigator

Matthew Butler M.D.

An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (CTMS# 18-0071)

This is an open-label, single arm, Phase 2 study evaluating the efficacy and safety of avapritinib (BLU-285) in patients with advanced systemic mastocytosis (AdvSM), including patients with aggressive SM (ASM), SM with associated hematologic neoplasm (SM-AHN), and mast cell leukemia (MCL)

Matthew Butler, M.D.

About Matthew Butler, M.D.

Gender

Credentials

Certifications

Education

Locations & Contact

Urschel Building

29.5130016, -98.5806009

Dr. Butler is very informative. He's easy to speak to. He's very caring and I really liked his bed side manner.

Research & Publications

No Research & Publications

Clinical Trials

An Open-label, Single Arm, Phase 2 Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (CTMS# 18-0071)